Literature DB >> 24739782

Occludin deficiency with BACE1 elevation in cerebral amyloid angiopathy.

Xin Cheng1, Ping He, Hailan Yao, Qiang Dong, Rena Li, Yong Shen.   

Abstract

OBJECTIVE: A significant cause of spontaneous hemorrhages in the elderly is cerebral amyloid angiopathy (CAA), which causes degeneration of cerebral vessels, but the mechanisms are unclear.
METHODS: We isolated leptomeningeal vessels from rapidly autopsied brains (the average of postmortem intervals was 3.28 hours) from 9 patients with CAA and 10 age-matched controls, and used molecular, cell biology, and immunohistochemical approaches to examine β-site APP-cleaving enzyme 1 (BACE1) protein expression and enzymatic activities as well as tight junction molecular components in small- and medium-sized arteries of the cerebral cortex and leptomeninges.
RESULTS: We not only identified that the cerebral vessels, including leptomeningeal and cortical vessels, synthesize and express BACE1, but also found a significant elevation of both BACE1 protein levels and enzymatic activities in leptomeningeal vessels from patients with CAA. Moreover, overexpression of BACE1 in endothelial cells resulted in a significant reduction of occludin, a tight junction protein in blood vessels.
CONCLUSION: These findings suggest that in addition to neurons, cerebral vascular cells express functional BACE1. Moreover, elevated vascular BACE1 may contribute to deficiency of occludin in cerebral vessels, which ultimately has a critical role in pathogenesis of CAA and its related hemorrhage.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24739782      PMCID: PMC4032211          DOI: 10.1212/WNL.0000000000000403

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

1.  BACE1 is the major beta-secretase for generation of Abeta peptides by neurons.

Authors:  H Cai; Y Wang; D McCarthy; H Wen; D R Borchelt; D L Price; P C Wong
Journal:  Nat Neurosci       Date:  2001-03       Impact factor: 24.884

2.  Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation.

Authors:  Y Luo; B Bolon; S Kahn; B D Bennett; S Babu-Khan; P Denis; W Fan; H Kha; J Zhang; Y Gong; L Martin; J C Louis; Q Yan; W G Richards; M Citron; R Vassar
Journal:  Nat Neurosci       Date:  2001-03       Impact factor: 24.884

3.  Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease.

Authors:  R M Damian Holsinger; Catriona A McLean; Konrad Beyreuther; Colin L Masters; Geneviève Evin
Journal:  Ann Neurol       Date:  2002-06       Impact factor: 10.422

4.  Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease.

Authors:  Li-Bang Yang; Kristina Lindholm; Riqiang Yan; Martin Citron; Weiming Xia; Xiao-Li Yang; Thomas Beach; Lucia Sue; Philip Wong; Donald Price; Rena Li; Yong Shen
Journal:  Nat Med       Date:  2003-01       Impact factor: 53.440

5.  Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.

Authors:  Rena Li; Kristina Lindholm; Li-Bang Yang; Xu Yue; Martin Citron; Riqiang Yan; Thomas Beach; Lucia Sue; Marwan Sabbagh; Huaibin Cai; Philip Wong; Donald Price; Yong Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205

6.  Purification and cloning of amyloid precursor protein beta-secretase from human brain.

Authors:  S Sinha; J P Anderson; R Barbour; G S Basi; R Caccavello; D Davis; M Doan; H F Dovey; N Frigon; J Hong; K Jacobson-Croak; N Jewett; P Keim; J Knops; I Lieberburg; M Power; H Tan; G Tatsuno; J Tung; D Schenk; P Seubert; S M Suomensaari; S Wang; D Walker; J Zhao; L McConlogue; V John
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

7.  High activities of BACE1 in brains with mild cognitive impairment.

Authors:  Xin Cheng; Ping He; Taehee Lee; Hailan Yao; Rena Li; Yong Shen
Journal:  Am J Pathol       Date:  2014-01       Impact factor: 4.307

8.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.

Authors:  R Vassar; B D Bennett; S Babu-Khan; S Kahn; E A Mendiaz; P Denis; D B Teplow; S Ross; P Amarante; R Loeloff; Y Luo; S Fisher; J Fuller; S Edenson; J Lile; M A Jarosinski; A L Biere; E Curran; T Burgess; J C Louis; F Collins; J Treanor; G Rogers; M Citron
Journal:  Science       Date:  1999-10-22       Impact factor: 47.728

9.  Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease.

Authors:  Hiroaki Fukumoto; Bonnie S Cheung; Bradley T Hyman; Michael C Irizarry
Journal:  Arch Neurol       Date:  2002-09

10.  Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease.

Authors:  Alex E Roher; Yu-Min Kuo; Chera Esh; Carmen Knebel; Nicole Weiss; Walter Kalback; Dean C Luehrs; Jennifer L Childress; Thomas G Beach; Roy O Weller; Tyler A Kokjohn
Journal:  Mol Med       Date:  2003 Mar-Apr       Impact factor: 6.354

View more
  15 in total

1.  Blood cell-produced amyloid-β induces cerebral Alzheimer-type pathologies and behavioral deficits.

Authors:  Hao-Lun Sun; Si-Han Chen; Zhong-Yuan Yu; Yuan Cheng; Ding-Yuan Tian; Dong-Yu Fan; Chen-Yang He; Jun Wang; Pu-Yang Sun; Yang Chen; Cheng-Rong Tan; Jun-Ping Wang; Weihong Song; Hua-Dong Zhou; Xiao-Wei Chen; Zhi-An Hu; Xian-Le Bu; Yan-Jiang Wang
Journal:  Mol Psychiatry       Date:  2020-07-17       Impact factor: 15.992

2.  Non-neuronal and neuronal BACE1 elevation in association with angiopathic and leptomeningeal β-amyloid deposition in the human brain.

Authors:  Zhi-Qin Xue; Zheng-Wen He; Jian-Jun Yu; Yan Cai; Wen-Ying Qiu; Aihua Pan; Wei-Ping Gai; Huaibin Cai; Xue-Gang Luo; Chao Ma; Xiao-Xin Yan
Journal:  BMC Neurol       Date:  2015-05-02       Impact factor: 2.474

Review 3.  Amyloidosis in Retinal Neurodegenerative Diseases.

Authors:  Ambra Masuzzo; Virginie Dinet; Chelsea Cavanagh; Frederic Mascarelli; Slavica Krantic
Journal:  Front Neurol       Date:  2016-08-08       Impact factor: 4.003

4.  Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine?

Authors:  Jian-Ming Li; Li-Ling Huang; Fei Liu; Bei-Sha Tang; Xiao-Xin Yan
Journal:  BMC Neurol       Date:  2017-08-25       Impact factor: 2.474

5.  Sortilin Fragments Deposit at Senile Plaques in Human Cerebrum.

Authors:  Xia Hu; Zhao-Lan Hu; Zheng Li; Chun-Sheng Ruan; Wen-Ying Qiu; Aihua Pan; Chang-Qi Li; Yan Cai; Lu Shen; Yaping Chu; Bei-Sha Tang; Huaibin Cai; Xin-Fu Zhou; Chao Ma; Xiao-Xin Yan
Journal:  Front Neuroanat       Date:  2017-06-07       Impact factor: 3.856

6.  Establishment and evaluation of an experimental rat model for high-altitude intestinal barrier injury.

Authors:  Han Luo; Dai-Jun Zhou; Zhang Chen; Qi-Quan Zhou; Kui Wu; Kun Tian; Zhi-Wei Li; Zhen-Liang Xiao
Journal:  Exp Ther Med       Date:  2016-12-29       Impact factor: 2.447

7.  Elevated circulating amyloid concentrations in obesity and diabetes promote vascular dysfunction.

Authors:  Paul J Meakin; Bethany M Coull; Zofia Tuharska; Christopher McCaffery; Ioannis Akoumianakis; Charalambos Antoniades; Jane Brown; Kathryn J Griffin; Fiona Platt; Claire H Ozber; Nadira Y Yuldasheva; Natallia Makava; Anna Skromna; Alan Prescott; Alison D McNeilly; Moneeza Siddiqui; Colin Na Palmer; Faisel Khan; Michael Lj Ashford
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

Review 8.  BACE1: More than just a β-secretase.

Authors:  Hannah A Taylor; Lena Przemylska; Eva M Clavane; Paul J Meakin
Journal:  Obes Rev       Date:  2022-02-04       Impact factor: 10.867

9.  Blood-Brain Barrier Dysfunction in Small Vessel Disease Related Intracerebral Hemorrhage.

Authors:  Whitney M Freeze; Heidi I L Jacobs; Floris H B M Schreuder; Robert J van Oostenbrugge; Walter H Backes; Frans R Verhey; Catharina J M Klijn
Journal:  Front Neurol       Date:  2018-11-12       Impact factor: 4.003

10.  The amyloid-β degradation intermediate Aβ34 is pericyte-associated and reduced in brain capillaries of patients with Alzheimer's disease.

Authors:  Tunahan Kirabali; Serena Rigotti; Alessandro Siccoli; Filip Liebsch; Adeola Shobo; Christoph Hock; Roger M Nitsch; Gerhard Multhaup; Luka Kulic
Journal:  Acta Neuropathol Commun       Date:  2019-12-03       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.